Recall of LeadCare® blood lead tests due to risk of falsely low results

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Recall of LeadCare® blood lead tests due to risk of falsely low results

July 06, 2021
By Centers for Disease Control and Prevention (U.S.
Series: HAN ; 445

[PDF-187.53 KB]

English

Details Supporting Files Related Documents You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.
Description:

Distributed via the CDC Health Alert Network

July 06, 2021, 12:00 PM ET

CDCHAN-00445

Magellan Diagnostics, Inc. and the U.S. Food and Drug Administration (FDA) have issued a recall notice concerning the use of some LeadCare® Blood Lead Tests (certain LeadCare II, LeadCare Plus, and LeadCare Ultra test kit lots). These lots were distributed between October 27, 2020, and June 15, 2021. The use of these devices may cause serious injuries because they might underestimate blood lead levels. The FDA has identified this as a Class I recall, the most serious type of recall.

The purpose of this Centers for Disease Control and Prevention (CDC) Health Alert Network (HAN) Health Advisory is to notify healthcare providers and state and local health departments about this recall notice and to recommend appropriate follow-up actions.
Subjects:

[+]

Lead/blood Lead Poisoning/diagnosis Mass Screening Product Recalls And Withdrawals
Series:

HAN ; 445
Document Type:

HAN Health Advisory
Name as Subject:

National Respiratory and Enteric Virus Surveillance System (U.S.) ; National Respiratory and Enteric Virus Surveillance System (U.S.)

National Respiratory and Enteric Virus Surveillance System (U.S.) ; National Respiratory and Enteric Virus Surveillance System (U.S.) Less -
Issue:

445
Collection(s):

Health Alert Network (HAN)
Main Document Checksum:

[+]

urn:sha-512:1aadeded5a14c42ba4a81c0c92ae641135f5895dce8573b946708c8de6585734b60ba0f4eda2c09cbbe455dfac3df087ad96e2eeb8bae0f503467f905642a774
Download URL:

https://stacks.cdc.gov/view/cdc/107703/cdc_107703_DS1.pdf
File Type:

han00444.asp

bin

More +